正文
《医学前沿(英文)》 >> 2021年 第15卷 第2期 doi: 10.1007/s11684-020-0812-7
mTOR-targeted cancer therapy: great target but disappointing clinical outcomes, why?
Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute, Atlanta, GA 30322, USA
摘要
关键词
mTOR ; cancer therapy ; resistance ; GSK3 ; protein degradation ; E3 ubiquitin ligase ; PD-L1
正文